Metabolic & Weight

Research compounds studied for energy balance, glucose handling, mitochondrial function, appetite signaling, and metabolic adaptation.

5-Amino-1MQ

5-Amino-1MQ is a non-peptide NNMT inhibitor studied in metabolic and adipose-tissue research models.

AOD-9604 is a modified hGH fragment studied for lipid metabolism and obesity-related research.

Cagrilintide is a long-acting amylin analog studied for appetite, satiety, and body-weight research.

LIPO-C refers to lipotropic injection blends commonly discussed for metabolic support, but it is not a peptide.

Mazdutide is a dual GLP-1 and glucagon receptor agonist studied for weight management and metabolic effects.

MOTS-c is a mitochondria-derived peptide studied for metabolic regulation, insulin sensitivity, and aging biology.

Retatrutide is a triple receptor agonist studied for obesity, glucose control, and metabolic disease research.

Semaglutide is a GLP-1 receptor agonist studied and used clinically for glucose control and chronic weight-management indications.

SLU-PP-332 is a synthetic estrogen-related receptor agonist studied as an exercise mimetic for metabolism and endurance in preclinical models.

Tesamorelin is a GHRH analog studied for visceral adiposity and GH-axis metabolic effects.

Tirzepatide is a dual GIP and GLP-1 receptor agonist studied for metabolic disease and weight-management outcomes.